Abstract
OC-0480: Five-year clinical outcome of the Phase III ACCORD 12 neoadjuvant trial in rectal cancer
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have